Specifications Sources & References Peer-reviewed research Journal of Clinical Endocrinology & Metabolism Prolonged stimulation of GH and IGF-I secretion by CJC-1295 2006 DOI: 10.1210/jc.2005-1536 PMID: 16384850 Teichman SL, Neale A, Lawrence B, et al
GHK-Cu 50mg is supplied strictly as a research chemical for in-vitro laboratory use
Effects of dietary glycine supplementation on concentrations of GSH and GSSG in tissues Data on the concentrations of GSH and GSSG in the tissues of Phase-I HSB are summarized in Table 2
References Abreu R.V., Silva-Oliveira E.M., Moraes M.F.D., Pereira G.S., Moraes-Santos T
To gain a better understanding of PQQ therapeutic applications and its potential benefits, further human clinical trials are needed based on in vivo studies
For TB-500, research protocols commonly reference loading-phase doses of approximately 2-2.5mg twice weekly during the initial period, transitioning to maintenance doses of approximately 2-2.5mg once weekly or every other week
